Stephens Consulting’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-9
Closed -$1.08K – 551
2025
Q2
$1.08K Buy
+9
New +$1.2K ﹤0.01% 641
2024
Q1
– Sell
-50
Closed -$7.13K – 479
2023
Q4
$7.13K Hold
50
– – ﹤0.01% 346
2023
Q3
$6.55K Hold
50
– – ﹤0.01% 355
2023
Q2
$7.95K Hold
50
– – ﹤0.01% 335
2023
Q1
$7.91K Hold
50
– – ﹤0.01% 353
2022
Q4
$7.02K Hold
50
– – ﹤0.01% 340
2022
Q3
$6.42K Hold
50
– – 0.01% 385
2022
Q2
$7.05K Hold
50
– – 0.01% 372
2022
Q1
$6.95K Hold
50
– – 0.01% 396
2021
Q4
$8.72K Buy
+50
New +$8.34K 0.01% 416

Other funds holding CLX

Stephens Consulting's CLX Position: Q3 2025 in Review

Stephens Consulting sold out of Clorox (CLX) in Q3 2025, closing a stake of 9 shares — an estimated $1.08K sold.

Stephens Consulting first reported a position in CLX in Q4 2021 and held it in 10 quarters. The position peaked at $8.72K in Q4 2021. 1,094 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

  • Stephens Consulting reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
  • Stephens Consulting sold 9 Clorox shares in Q3 2025, an estimated $1.08K.
  • Stephens Consulting first reported a position in Clorox in Q4 2021 and held it in 10 quarters.
  • Stephens Consulting's Clorox position peaked at $8.72K in Q4 2021.
  • 1,094 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.